LVM Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.6M Sell
29,133
-596
-2% -$204K 0.88% 32
2026
Q1
$10.5M Sell
29,729
-478
-2% -$170K 0.99% 30
2025
Q4
$9.89M Sell
30,207
-81
-0.3% -$25.7K 0.92% 31
2025
Q3
$8.55M Sell
30,288
-333
-1% -$96.6K 0.82% 32
2025
Q2
$8.55M Sell
30,621
-350
-1% -$99.2K 0.89% 33
2025
Q1
$9.65M Sell
30,971
-9,700
-24% -$2.86M 1.07% 29
2024
Q4
$10.6M Sell
40,671
-19,490
-32% -$5.78M 1.14% 27
2024
Q3
$18.8M Hold
60,161
2.14% 15
2024
Q2
$18.8M Buy
60,161
+304
+0.5% +$89.3K 2.14% 15
2024
Q1
$17M Buy
59,857
+2,320
+4% +$679K 2.01% 16
2023
Q4
$16.6M Buy
57,537
+358
+0.6% +$97.5K 2.12% 14
2023
Q3
$15.4M Sell
57,179
-2,451
-4% -$612K 2.17% 14
2023
Q2
$13.2M Sell
59,630
-245
-0.4% -$56.8K 1.77% 18
2023
Q1
$14.5M Buy
59,875
+1,040
+2% +$255K 2.01% 14
2022
Q4
$15.5M Sell
58,835
-1,725
-3% -$462K 2.24% 13
2022
Q3
$13.7M Buy
60,560
+10
+0% +$2.42K 2.09% 14
2022
Q2
$14.7M Sell
60,550
-1,056
-2% -$259K 2.14% 14
2022
Q1
$14.9M Buy
61,606
+89
+0.1% +$20.4K 1.97% 16
2021
Q4
$13.8M Sell
61,517
-985
-2% -$208K 1.85% 19
2021
Q3
$13.3M Sell
62,502
-933
-1% -$215K 2% 19
2021
Q2
$15.5M Sell
63,435
-426
-0.7% -$105K 2.36% 14
2021
Q1
$15.9M Sell
63,861
-2,746
-4% -$655K 2.58% 12
2020
Q4
$15.3M Buy
66,607
+1,037
+2% +$239K 2.58% 12
2020
Q3
$16.7M Buy
65,570
+301
+0.5% +$74.6K 3.23% 8
2020
Q2
$15.4M Sell
65,269
-190
-0.3% -$43.4K 3.16% 8
2020
Q1
$13.3M Buy
65,459
+3,420
+6% +$747K 3.27% 8
2019
Q4
$15M Sell
62,039
-708
-1% -$156K 2.95% 9
2019
Q3
$12.1M Buy
62,747
+1,689
+3% +$324K 2.58% 13
2019
Q2
$11.3M Buy
61,058
+792
+1% +$142K 2.56% 14
2019
Q1
$11.4M Sell
60,266
-20,239
-25% -$3.87M 2.63% 12
2018
Q4
$15.7M Buy
80,505
+1,318
+2% +$257K 4.11% 7
2018
Q3
$16.4M Sell
79,187
-1,710
-2% -$337K 3.75% 8
2018
Q2
$14.9M Buy
80,897
+200
+0.2% +$35.4K 3.6% 8
2018
Q1
$13.8M Sell
80,697
-2,290
-3% -$420K 3.17% 11
2017
Q4
$14.4M Buy
82,987
+780
+0.9% +$138K 3.26% 9
2017
Q3
$15.3M Buy
82,207
+2,085
+3% +$369K 3.66% 7
2017
Q2
$13.8M Buy
80,122
+3,832
+5% +$623K 3.52% 9
2017
Q1
$12.5M Buy
76,290
+1,000
+1% +$166K 3.22% 9
2016
Q4
$11M Buy
+75,290
New +$11.3M 3.04% 10
2016
Q3
Sell
-69,845
Closed -$10.6M 112
2016
Q2
$10.6M Buy
69,845
+1,225
+2% +$190K 3.08% 11
2016
Q1
$10.3M Buy
68,620
+32,710
+91% +$4.86M 3.26% 10
2015
Q4
$5.83M Buy
35,910
+1,465
+4% +$230K 2.06% 22
2015
Q3
$4.76M Buy
34,445
+32,845
+2,053% +$5.18M 1.72% 24
2015
Q2
$246K Hold
1,600
0.08% 97
2015
Q1
$256K Hold
1,600
0.09% 94
2014
Q4
$255K Hold
1,600
0.08% 96
2014
Q3
$225K Buy
+1,600
New +$209K 0.07% 99

Other funds holding AMGN

LVM Capital Management's AMGN Position: Q2 2026 in Review

LVM Capital Management reduced its Amgen (AMGN) stake by 2% in Q2 2026, selling an estimated $204K and leaving 29,133 shares worth $10.6M. The position accounts for 0.88% of the portfolio, ranked #32.

LVM Capital Management first reported a position in AMGN in Q3 2014 and has held it in 47 quarters since. The position peaked at $18.8M in Q3 2024. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • LVM Capital Management held 29,133 shares of Amgen worth $10.6M as of Q2 2026.
  • LVM Capital Management sold 596 Amgen shares in Q2 2026, an estimated $204K.
  • Amgen made up 0.88% of LVM Capital Management's portfolio in Q2 2026, its #32 holding.
  • LVM Capital Management first reported a position in Amgen in Q3 2014 and has held it in 47 quarters since.
  • LVM Capital Management's Amgen position peaked at $18.8M in Q3 2024.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on LVM Capital Management's 13F filing for Q2 2026, filed 9 Jul 2026.